Laboratory diagnosis of Ebola virus disease and corresponding biosafety considerations in the China Ebola Treatment Center

References

• Bukreyev AA, Chandran K, Dolnik O, et al. Discussions and decisions of the 2012–2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012–June 2013. Arch Virol 2014;159:821–30.
   PubMed Web of Science ®Google Scholar
• Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 2014;371:1418–25.
   PubMed Web of Science ®Google Scholar
• Gire SK, Goba A, Andersen KG, et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 2014;345:1369–72.
   PubMed Web of Science ®Google Scholar
• Bausch DG, Schwarz L. Outbreak of Ebola virus disease in Guinea: where ecology meets economy. PLoS Negl Trop Dis 2014;8:e3056.
   PubMed Web of Science ®Google Scholar
• Bah EI, Lamah MC, Fletcher T, et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med 2015;372:40–7.
   PubMed Web of Science ®Google Scholar
• Lyon GM, Mehta AK, Varkey JB, et al. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med 2014;371:2402–9.
   PubMed Web of Science ®Google Scholar
• Meyers L, Frawley T, Goss S, et al. Ebola virus outbreak 2014: clinical review for emergency physicians. Ann Emerg Med 2015;65:101–8.
   PubMed Web of Science ®Google Scholar
• Yamin D, Gertler S, Ndeffo-Mbah ML, et al. Effect of Ebola progression on transmission and control in Liberia. Ann Intern Med 2015;162:11–17.
   PubMed Web of Science ®Google Scholar
• Tseng CP, Chan YJ. Overview of Ebola virus disease in 2014. J Chin Med Assoc 2015;78:51–5.
   PubMed Web of Science ®Google Scholar
• Nyenswah T, Fahnbulleh M, Massaquoi M, et al. Ebola epidemic-Liberia, March-October 2014. MMWR Morb Mortal Wkly Rep 2014;63:1082–6.
   PubMed Web of Science ®Google Scholar
• You JQ. An improved ward architecture for treatment of patients with Ebola virus disease in Liberia. Am J Trop Med Hyg 2016. [Epub ahead of print]. doi: 10.4269/ajtmh.15-0209.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Diagnosis. [Online] 14 November 2014. [Updated] 25 April 2015. Available from: http://www.cdc.gov/vhf/ebola/diagnosis/index.html [last accessed 17 Sep 2015].
   Google Scholar
• Beeching NJ, Fenech M, Houlihan CF. Ebola virus disease. BMJ 2014;349:g7348.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Laboratory guidance for the diagnosis of Ebola virus disease: interim recommendations. [Online] 19 Septermber 2014. Available from: http://apps.who.int/iris/handle/10665/134009 [last accessed 17 Sep 2015].
   Google Scholar
• Saijo M, Niikura M, Ikegami T, et al. Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins. Clin Vaccine Immunol 2006;13:444–51.
   PubMed Web of Science ®Google Scholar
• Drosten C, Gottig S, Schilling S, et al. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol 2002;40:2323–30.
   PubMed Web of Science ®Google Scholar
• Gibb TR, Norwood DA, Jr, Woollen N, et al. Development and evaluation of a fluorogenic 5' nuclease assay to detect and differentiate between Ebola virus subtypes Zaire and Sudan. J Clin Microbiol 2001;39:4125–30.
   PubMed Web of Science ®Google Scholar
• Ksiazek TG, Rollin PE, Jahrling PB, et al. Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J Clin Microbiol 1992;30:947–50.
   PubMed Web of Science ®Google Scholar
• Ksiazek TG, Rollin PE, Williams AJ, et al. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999;179:S177–87.
   PubMed Web of Science ®Google Scholar
• Ksiazek TG, West CP, Rollin PE, et al. ELISA for the detection of antibodies to Ebola viruses. J Infect Dis 1999;179:S192–8.
   Web of Science ®Google Scholar
• Leroy EM, Baize S, Lu CY, et al. Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting. J Med Virol 2000;60:463–7.
   PubMed Web of Science ®Google Scholar
• Wang YP, Zhang XE, Wei HP. Laboratory detection and diagnosis of filoviruses. Virol Sin 2011;26:73–80.
   PubMedGoogle Scholar
• Huang Y, Wei H, Wang Y, et al. Rapid detection of filoviruses by real-time TaqMan polymerase chain reaction assays. Virol Sin 2012;27:273–7.
   PubMedGoogle Scholar
• Huang Y, Zhu Y, Yang M, et al. Nucleoprotein-based indirect enzyme-linked immunosorbent assay (indirect ELISA) for detecting antibodies specific to Ebola virus and Marbug virus. Virol Sin 2014;29:372–80.
   PubMedGoogle Scholar
• Kreuels B, Wichmann D, Emmerich P, et al. A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med 2014;371:2394–401.
   PubMed Web of Science ®Google Scholar
• Alimonti J, Leung A, Jones S, et al. Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory. Sci Rep 2014;4:5824. doi: 10.1038/srep05824.
   PubMed Web of Science ®Google Scholar
• Towner JS, Rollin PE, Bausch DG, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004;78:4330–41.
   PubMed Web of Science ®Google Scholar
• Formenty P, Leroy EM, Epelboin A, et al. Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis 2006;42:1521–6.
   PubMed Web of Science ®Google Scholar
• Yan L, Zhou J, Zheng Y, et al. Isothermal amplified detection of DNA and RNA. Mol Biosyst 2014;10:970–1003.
   PubMed Web of Science ®Google Scholar
• Chang CC, Chen CC, Wei SC, et al. Diagnostic devices for isothermal nucleic acid amplification. Sensors (Basel) 2012;12:8319–37.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Review of Human-to-Human Transmission of Ebola Virus. [Online] 12 July 2015 [Updated] 1 October 2015. Available from: http://www.cdc.gov/vhf/ebola/transmission/human-transmission.html [last accessed 10 Oct 2015].
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Questions and Answers about Ebola, Pets, and Other Animals. [Online] 27 April 2015. Available from: http://www.cdc.gov/vhf/ebola/transmission/qas-pets.html [last accessed 17 Sep 2015].
   Google Scholar
• World Health Organization (WHO). Frequently asked questions on Ebola virus disease. [Online] Augest 2015. Available from: http://www.who.int/csr/disease/ebola/faq-ebola/en/ [last accessed 17 Sep 2015].
   Google Scholar
• Dowell SF, Mukunu R, Ksiazek TG, et al. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 1999;179:S87–91.
   PubMed Web of Science ®Google Scholar
• Mossong J, Hens N, Jit M, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008;5:e74.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 1978;56:271–93.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Guidance for collection, transport and submission of specimens for Ebola virus testing. [Online] 30 January 2015. Available from: http://www.cdc.gov/vhf/ebola/healthcare-us/laboratories/specimens.html [last accessed 5 Jan 2016].
   Google Scholar
• Iwen PC, Garrett JL, Gibbs SG, et al. An integrated approach to laboratory testing for patients with Ebola virus disease. Lab Med 2014;45:e146–51.
   PubMed Web of Science ®Google Scholar
• Iwen PC, Smith PW, Hewlett AL, et al. Safety considerations in the laboratory testing of specimens suspected or known to contain Ebola virus. Am J Clin Pathol 2015;143:4–5.
   PubMed Web of Science ®Google Scholar
• Hill CE, Burd EM, Kraft CS, et al. Laboratory test support for Ebola patients within a high-containment facility. Lab Med 2014;45:e109–11.
   PubMedGoogle Scholar
• Khan AS, Tshioko FK, Heymann DL, Commission de Lutte contre les Epidemies a Kikwit, et al. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. J Infect Dis 1999;179:S76–86
   PubMed Web of Science ®Google Scholar
• Mitchell SW, McCormick JB. Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses. J Clin Microbiol 1984;20:486–9.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Infection prevention and control guidance for care of patients in health-care settings, with focus on Ebola 2014. [Online] December 2014. Available from: http://www.who.int/csr/resources/publications/ebola/filovirus_infection_control/en/ [last accessed 5 Jan 2016].
   Google Scholar
• Elliott LH, McCormick JB, Johnson KM. Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation. J Clin Microbiol 1982;16:704–8.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Categorization and prioritization of drugs for consideration for testing or use in patients infected with Ebola 2015. [Update] 3 July 2015. Available from: http://www.who.int/medicines/ebola-treatment/cat_prioritization_drugs_testing/en/ [last accessed 5 Jan 2016].
   Google Scholar
• Kugelman JR, Sanchez-Lockhart M, Andersen KG, et al. Evaluation of the potential impact of Ebola virus genomic drift on the efficacy of sequence-based candidate therapeutics. MBio 2015;6 : e02227-14.
   PubMed Web of Science ®Google Scholar
• Gulland A. Ebola drug trial is to start next month. BMJ 2014;349:g6436.
   PubMed Web of Science ®Google Scholar
• Galvani AP, Ndeffo-Mbah ML, Wenzel N, et al. Ebola vaccination: if not now, when? Ann Intern Med 2014;161:749–50.
   PubMed Web of Science ®Google Scholar
• Gulland A. Vaccine tests to begin in Ebola countries this year. BMJ 2014;349:g6466.
   PubMed Web of Science ®Google Scholar
• Link C Jr, Cohen J. Infectious diseases. The Ebola vaccine underdog. Science 2014;346:534.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Case definition for Ebola Virus Disease (EVD). [Online] 16 November 2014. Available from: http://www.cdc.gov/vhf/ebola/healthcare-us/evaluating-patients/case-definition.html [last accessed 17 Sep 2015].
   Google Scholar
• World Health Organization (WHO). Case definition recommendations for Ebola or Marburg Virus Diseases. [Online] August 2014. Available from: http://www.who.int/csr/resources/publications/ebola/case-definition/en/ [last accessed 17 Sep 2015].
   Google Scholar
• World Health Organization (WHO). How to safely collect oral swabs from deceased patients suspected to be infected with Ebola. [Online] October 2014. Available from: http://www.who.int/csr/resources/publications/ebola/safely-collect-oral-swabs/en/ [last accessed 17 Sep 2015].
   Google Scholar
• World Health Organization (WHO). How to safely ship human blood samples from suspected Ebola cases within a country by road, rail and sea. [Online] November 2014. Available from: http://www.who.int/csr/resources/publications/ebola/blood-shipment/en/ [last accessed 17 Sep 2015].
   Google Scholar
• World Health Organization (WHO). How to safely collect blood samples from persons suspected to be infected with highly infectious blood-borne pathogens (e.g. Ebola). [Online] August 2014. Available from: http://www.who.int/csr/resources/publications/ebola/blood-collect/en/ [last accessed 17 Sep 2015].
   Google Scholar
• World Health Organization (WHO). Guidance on regulations for the Transport of Infectious Substances 2015-2016. [Online] January 2015. Available from: http://www.who.int/ihr/publications/who_hse_ihr_2015.2/en/ [last accessed 17 Sep 2015].
   Google Scholar
• McCarthy M. US issues new guidelines for health workers caring for Ebola patients. BMJ 2014;349:g6418.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Guidance on personal protective equipment (PPE) to be used by healthcare workers during management of patients with confirmed Ebola or persons under investigation (PUIs) for Ebola who are clinically unstable or have bleeding, vomiting, or diarrhea in U.S. hospitals, including procedures for donning and doffing PPE. [Online] 27 August 2015. Available from: http://www.cdc.gov/vhf/ebola/hcp/procedures-for-ppe.html [last accessed 17 Sep 2015].
   Google Scholar
• Edmond MB, Diekema DJ, Perencevich EN. Ebola virus disease and the need for new personal protective equipment JAMA 2014;312:2495–6.
   PubMed Web of Science ®Google Scholar
• Huang Q, Yao CY, Chen B, et al. Species-specific identification by inhibitor-controlled PCR of ruminant components contaminating industrial crude porcine heparin. Mol Cell Probes 2006;20:250–8.
   PubMed Web of Science ®Google Scholar
• Yoshizawa JM, Schafer CA, Schafer JJ, et al. Salivary biomarkers: toward future clinical and diagnostic utilities. Clin Microbiol Rev 2013;26:781–91.
   PubMed Web of Science ®Google Scholar
• Nielsen CF, Kidd S, Sillah AR, et al. Improving burial practices and cemetery management during an Ebola virus disease epidemic – Sierra Leone, 2014. Morb Mortal Wkly Rep 2015;64:20–7.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). How U.S. clinical laboratories can safely manage specimens from persons under investigation for Ebola virus disease. [Online] 12 November 2014. Available from: http://www.cdc.gov/vhf/ebola/hcp/safe-specimen-management.html [last accessed 23 Mar 2015].
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Ebola virus disease Information for Healthcare Workers and Settings. [Online] 4 March 2015. Available from: http://www.cdc.gov/vhf/ebola/hcp/index.html [last accessed 10 Sep 2015].
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Considerations for discharging persons under investigation (PUI) for Ebola Virus Disease (Ebola). [Online] 2 March 2015. Available from: http://www.cdc.gov/vhf/ebola/healthcare-us/evaluating-patients/discharging.html [last accessed 10 Sep 2015].
   Google Scholar
• Martin P, Laupland KB, Frost EH, et al. Laboratory diagnosis of Ebola virus disease. Intensive Care Med 2015;41:895–8.
   PubMed Web of Science ®Google Scholar
• Fletcher TE, Fowler RA, Beeching NJ. Understanding organ dysfunction in Ebola virus disease. Intensive Care Med 2014;40:1936–9.
   PubMed Web of Science ®Google Scholar
• Chertow DS, Kleine C, Edwards JK, et al. Ebola virus disease in West Africa-clinical manifestations and management. N Engl J Med 2014;371:2054–7.
   PubMed Web of Science ®Google Scholar
• Schieffelin JS, Shaffer JG, Goba A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med 2014;371:2092–100.
   PubMed Web of Science ®Google Scholar
• Kortepeter MG, Bausch DG, Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever. J Infect Dis 2011;204:S810–16.
   PubMed Web of Science ®Google Scholar
• Bausch DG, Towner JS, Dowell SF, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007;196:S142–7.
   PubMed Web of Science ®Google Scholar
• Geisbert TW, Jahrling PB. Exotic emerging viral diseases: progress and challenges. Nat Med 2004;10:S110–21.
   PubMed Web of Science ®Google Scholar
• Mahanty S, Bray M. Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis 2004;4:487–98.
   PubMed Web of Science ®Google Scholar
• Bustin SA, Benes V, Garson JA, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009;55:611–22.
   PubMed Web of Science ®Google Scholar
• McElroy AK, Erickson BR, Flietstra TD, et al. Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome. J Infect Dis 2014;210:558–66.
   PubMed Web of Science ®Google Scholar
• Wu HM, Fairley JK, Steinberg J, et al. The potential Ebola-infected patient in the ambulatory care setting: preparing for the worst without compromising care. Ann Intern Med 2015;162:66–7.
   PubMed Web of Science ®Google Scholar
• Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet 2011;377:849–62.
   PubMed Web of Science ®Google Scholar
• Rollin PE, Bausch DG, Sanchez A. Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. J Infect Dis 2007;196:S364–71.
   PubMed Web of Science ®Google Scholar
• Blow JA, Dohm DJ, Negley DL, et al. Virus inactivation by nucleic acid extraction reagents. J Virol Methods 2004;119:195–8.
   PubMed Web of Science ®Google Scholar
• Craw P, Balachandran W. Isothermal nucleic acid amplification technologies for point-of-care diagnostics: a critical review. Lab Chip 2012;12:2469–86.
   PubMed Web of Science ®Google Scholar
• Drain PK, Hyle EP, Noubary F, et al. Diagnostic point-of-care tests in resource-limited settings. Lancet Infect Dis 2014;14:239–49.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). First Antigen Rapid Test for Ebola through Emergency Assessment and Eligible for Procurement. [Online] 2015. Available from: http://www.who.int/medicines/ebola-treatment/1st_antigen_RT_Ebola/en/ [last accessed 17 Sep 2015].
   Google Scholar
• Food and Drug Administration (FDA). Emergency Use Authorizations. [Online] 8 March 2015. Available from: http://www.fda.gov/MedicalDevices/Safety/EmergencySituations/ucm161496.htm [last accessed 17 Sep 2015].
   Google Scholar